在2024年11月14日举行的财报电话会议上，Akoya Biosciences（股票代码：AKYA）讨论了其第三季度财务业绩、运营挑战和战略举措。该公司报告2024年第三季度收入同比下降25%至1880万美元，主要由于资本设备采购减少。

Check out this evening’s top movers from around Wall Street, compiled by The Fly.   HIGHER AFTER EARNINGS –  Gain ...

Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, today announced its financial results for the third quarter ending September 30, 2024. “Our third-quarter results came ...

英为财情Investing.com - Akoya Biosciences (NASDAQ: AKYA )星期四发布了第三季度的财报，数据显示，公司营收逊于分析师的预期，每股收益低于分析师的预期。 在该公司发布的最新财报中，公司每股收益为$-0.210，总营收为$18.8M，而此前英为财情Investing.com对分析师的调查显示，分析师预期该公司的营收为$25.43M，每股收益为$-0.200 ...

Akoya Biosciences (AKYA) came out with a quarterly loss of $0.18 per share versus the Zacks Consensus Estimate of a loss of $0.19. This compares to loss of $0.26 per share a year ago. These figures ...

The life sciences sector often encounters complex risks that require specialized insurance solutions and deep industry expertise. Skyward Specialty's Life Sciences liability coverage delivers a ...

MARLBOROUGH, Mass. (AP) — MARLBOROUGH, Mass. (AP) — Akoya Biosciences Inc. (AKYA) on Thursday reported a loss of $10.5 million in its third quarter. On a per-share basis, the Marlborough, ...